Drug
Budesonide Nasal
Budesonide Nasal is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_4
1
20%
Ph not_applicable
1
20%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(2)
Detailed Status
unknown2
Withdrawn1
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
N/A1 (20.0%)
Trials by Status
withdrawn120%
active_not_recruiting120%
completed120%
unknown240%
Recent Activity
1 active trials
Showing 5 of 5
completedphase_3
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
NCT04361474
active_not_recruitingphase_4
Epigenetic Health Benefits of Budesonide
NCT04342039
unknownnot_applicable
Use of Budesonide Diluted to Maximum Clinical Treatment of Patients With Chronic Rhinosinusitis With Polyoposis.
NCT05541419
unknownphase_2
Ivermectin Nasal Drops in Post COVID-19 Parosmia
NCT05269030
withdrawnphase_3
Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients
NCT03303677
Clinical Trials (5)
Showing 5 of 5 trials
NCT04361474Phase 3
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity
NCT04342039Phase 4
Epigenetic Health Benefits of Budesonide
NCT05541419Not Applicable
Use of Budesonide Diluted to Maximum Clinical Treatment of Patients With Chronic Rhinosinusitis With Polyoposis.
NCT05269030Phase 2
Ivermectin Nasal Drops in Post COVID-19 Parosmia
NCT03303677Phase 3
Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5